Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 316

1.

Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids.

Alcala N, Leblay N, Gabriel AAG, Mangiante L, Hervas D, Giffon T, Sertier AS, Ferrari A, Derks J, Ghantous A, Delhomme TM, Chabrier A, Cuenin C, Abedi-Ardekani B, Boland A, Olaso R, Meyer V, Altmuller J, Le Calvez-Kelm F, Durand G, Voegele C, Boyault S, Moonen L, Lemaitre N, Lorimier P, Toffart AC, Soltermann A, Clement JH, Saenger J, Field JK, Brevet M, Blanc-Fournier C, Galateau-Salle F, Le Stang N, Russell PA, Wright G, Sozzi G, Pastorino U, Lacomme S, Vignaud JM, Hofman V, Hofman P, Brustugun OT, Lund-Iversen M, Thomas de Montpreville V, Muscarella LA, Graziano P, Popper H, Stojsic J, Deleuze JF, Herceg Z, Viari A, Nuernberg P, Pelosi G, Dingemans AMC, Milione M, Roz L, Brcic L, Volante M, Papotti MG, Caux C, Sandoval J, Hernandez-Vargas H, Brambilla E, Speel EJM, Girard N, Lantuejoul S, McKay JD, Foll M, Fernandez-Cuesta L.

Nat Commun. 2019 Aug 20;10(1):3407. doi: 10.1038/s41467-019-11276-9.

2.

Interobserver variation in the assessment of the sarcomatoid and transitional components in biphasic mesotheliomas.

Dacic S, Le Stang N, Husain A, Weynand B, Beasley MB, Butnor K, Chapel D, Gibbs A, Klebe S, Lantuejoul S, Roden AC, Roggli V, Tazelaar H, Vignaud JM, Galateau-Sallé F.

Mod Pathol. 2019 Jul 4. doi: 10.1038/s41379-019-0320-y. [Epub ahead of print]

PMID:
31273316
3.

Multicenter Evaluation of a Novel ROS1 Immunohistochemistry Assay (SP384) for Detection of ROS1 Rearrangements in a Large Cohort of Lung Adenocarcinoma Patients.

Hofman V, Rouquette I, Long-Mira E, Piton N, Chamorey E, Heeke S, Vignaud JM, Yguel C, Mazières J, Lepage AL, Bibeau F, Begueret H, Lassalle S, Lalvée S, Zahaf K, Benzaquen J, Poudenx M, Marquette CH, Sabourin JC, Ilié M, Hofman P.

J Thorac Oncol. 2019 Jul;14(7):1204-1212. doi: 10.1016/j.jtho.2019.03.024. Epub 2019 Apr 15.

PMID:
30999109
4.

COPPS, a composite score integrating pathological features, PS100 and SDHB losses, predicts the risk of metastasis and progression-free survival in pheochromocytomas/paragangliomas.

Pierre C, Agopiantz M, Brunaud L, Battaglia-Hsu SF, Max A, Pouget C, Nomine C, Lomazzi S, Vignaud JM, Weryha G, Oussalah A, Gauchotte G, Busby-Venner H.

Virchows Arch. 2019 Jun;474(6):721-734. doi: 10.1007/s00428-019-02553-5. Epub 2019 Mar 13.

PMID:
30868297
5.

[Use of the PELICAN software for the creation and export of standardized pathology reports in central nervous system tumors: Example of meningiomas].

Yguel C, Clauzon D, Lacomme S, Lomazzi S, Lardenois E, Pouget C, Taillandier L, Rech F, Rigau V, Vignaud JM, Bauchet L, Gauchotte G.

Ann Pathol. 2019 Mar 7. pii: S0242-6498(19)30032-X. doi: 10.1016/j.annpat.2019.01.016. [Epub ahead of print] French.

PMID:
30853495
6.

[Development and deployment of a standardized pathology report in lung cancer, basing on a data management software: The PELICAN software].

Yguel C, Clauzon D, Lacomme S, Siat J, Lomazzi S, Lardenois E, Taillandier L, Vignaud JM, Gauchotte G.

Ann Pathol. 2019 Apr;39(2):87-99. doi: 10.1016/j.annpat.2018.12.001. Epub 2019 Feb 6. French.

PMID:
30736988
7.

Well-Differentiated Papillary Mesothelioma of the Peritoneum: A Retrospective Study from the RENAPE Observational Registry.

Vogin G, Hettal L, Vignaud JM, Dartigues P, Goere D, Ferron G, Heyd B, Bereder JM, Tuech JJ, Glehen O, de Chaisemartin C, Lherm Y, Villeneuve L, Kepenekian V, Marchal F; RENAPE Network.

Ann Surg Oncol. 2019 Mar;26(3):852-860. doi: 10.1245/s10434-018-07153-2. Epub 2019 Jan 11.

PMID:
30635798
8.

Compartmentalized endoscopic resection of the olfactory cleft for nasal intestinal adenocarcinomas.

Russel A, Nguyen DT, Vigouroux C, Gallet P, Vignaud JM, Rumeau C, Jankowski R.

Head Neck. 2018 Nov;40(11):2389-2398. doi: 10.1002/hed.25349. Epub 2018 Jun 26.

PMID:
29947068
9.

New Insights on Diagnostic Reproducibility of Biphasic Mesotheliomas: A Multi-Institutional Evaluation by the International Mesothelioma Panel From the MESOPATH Reference Center.

Galateau Salle F, Le Stang N, Nicholson AG, Pissaloux D, Churg A, Klebe S, Roggli VL, Tazelaar HD, Vignaud JM, Attanoos R, Beasley MB, Begueret H, Capron F, Chirieac L, Copin MC, Dacic S, Danel C, Foulet-Roge A, Gibbs A, Giusiano-Courcambeck S, Hiroshima K, Hofman V, Husain AN, Kerr K, Marchevsky A, Nabeshima K, Picquenot JM, Rouquette I, Sagan C, Sauter JL, Thivolet F, Travis WD, Tsao MS, Weynand B, Damiola F, Scherpereel A, Pairon JC, Lantuejoul S, Rusch V, Girard N.

J Thorac Oncol. 2018 Aug;13(8):1189-1203. doi: 10.1016/j.jtho.2018.04.023. Epub 2018 Apr 30.

10.

[ROS-1 rearranged bronchopulmonary adenocarcinoma revealed by a pulmonary miliary].

Brindel A, Huet D, Vaillant P, Vignaud JM, Tiotiu A.

Bull Cancer. 2018 Jun;105(6):549-551. doi: 10.1016/j.bulcan.2018.03.007. Epub 2018 Apr 27. French. No abstract available.

PMID:
29706357
11.

[PD-L1 testing in non-small cell lung carcinoma: Guidelines from the PATTERN group of thoracic pathologists].

Lantuejoul S, Adam J, Girard N, Duruisseaux M, Mansuet-Lupo A, Cazes A, Rouquette I, Gibault L, Garcia S, Antoine M, Vignaud JM, Galateau-Sallé F, Sagan C, Badoual C, Penault-Llorca F, Damotte D; pour le groupe pathologistes thoraciques de valorisation de l’expertise, de la recherche et de l’innovation (PATTERN). Fondation Synergie Lyon Cancer.

Ann Pathol. 2018 Apr;38(2):110-125. doi: 10.1016/j.annpat.2018.01.007. Epub 2018 Mar 21. French.

PMID:
29571563
12.

Survival Impact of Stations of Pathological Lymph Nodes in N2 Non-small Cell Lung Cancer in a French Hospital.

Clément-Duchêne C, Luc A, Casse JM, Vignaud JM, Lacomme S, Anne V, Siat J, Ménard O, Martinet Y.

Ann Surg Oncol. 2018 May;25(5):1262-1268. doi: 10.1245/s10434-018-6373-1. Epub 2018 Feb 14.

PMID:
29450750
13.

Prognostic Value of Exon 19 Versus 21 EGFR Mutations Varies According to Disease Stage in Surgically Resected Non-small Cell Lung Cancer Adenocarcinoma.

Renaud S, Seitlinger J, Guerrera F, Reeb J, Beau-Faller M, Voegeli AC, Siat J, Clément-Duchêne C, Tiotiu A, Santelmo N, Costardi L, Ruffini E, Falcoz PE, Vignaud JM, Massard G.

Ann Surg Oncol. 2018 Apr;25(4):1069-1078. doi: 10.1245/s10434-018-6347-3. Epub 2018 Jan 23.

PMID:
29362963
14.

The computed tomography adrenal wash-out analysis properly classifies cortisol secreting adrenocortical adenomas.

Humbert AL, Lecoanet G, Moog S, Bouderraoui F, Bresler L, Vignaud JM, Chevalier E, Brunaud L, Klein M, Cuny T.

Endocrine. 2018 Mar;59(3):529-537. doi: 10.1007/s12020-018-1522-7. Epub 2018 Jan 13.

PMID:
29332161
15.

Minichromosome maintenance complex component 6 (MCM6) expression correlates with histological grade and survival in endometrioid endometrial adenocarcinoma.

Hotton J, Agopiantz M, Leroux A, Charra-Brunaud C, Marie B, Busby-Venner H, Morel O, Guéant JL, Vignaud JM, Battaglia-Hsu SF, Gauchotte G.

Virchows Arch. 2018 Apr;472(4):623-633. doi: 10.1007/s00428-017-2278-9. Epub 2017 Dec 14.

PMID:
29243125
16.

[Prophylactic radiotherapy in a single fraction of 10Gy at intervention pleural site in patient with malignant pleural mesothelioma: A retrospective monocentric cohort study].

Carette H, Faivre JC, Salleron J, Baumann AS, Uwer L, Clément-Duchêne C, Vignaud JM, Petit I, Siat J, Tiotiu A, Beckendorf V.

Cancer Radiother. 2017 Dec;21(8):774-783. doi: 10.1016/j.canrad.2017.06.011. Epub 2017 Nov 11. French.

PMID:
29132802
17.

Expression of neurotensin receptor 1 in endometrial adenocarcinoma is correlated with histological grade and clinical outcome.

Agopiantz M, Forgez P, Casse JM, Lacomme S, Charra-Brunaud C, Clerc-Urmès I, Morel O, Bonnet C, Guéant JL, Vignaud JM, Gompel A, Gauchotte G.

Virchows Arch. 2017 Oct;471(4):521-530. doi: 10.1007/s00428-017-2215-y. Epub 2017 Aug 24.

PMID:
28836043
18.

The differential diagnosis between pleural sarcomatoid mesothelioma and spindle cell/pleomorphic (sarcomatoid) carcinomas of the lung: evidence-based guidelines from the International Mesothelioma Panel and the MESOPATH National Reference Center.

Marchevsky AM, LeStang N, Hiroshima K, Pelosi G, Attanoos R, Churg A, Chirieac L, Dacic S, Husain A, Khoor A, Klebe S, Lantuejoul S, Roggli V, Vignaud JM, Weynard B, Sauter J, Henderson D, Nabeshima K, Galateau-Salle F.

Hum Pathol. 2017 Sep;67:160-168. doi: 10.1016/j.humpath.2017.07.015. Epub 2017 Aug 4. Review.

PMID:
28782639
19.

Cytoplasmic overexpression of RNA-binding protein HuR is a marker of poor prognosis in meningioma, and HuR knockdown decreases meningioma cell growth and resistance to hypoxia.

Gauchotte G, Hergalant S, Vigouroux C, Casse JM, Houlgatte R, Kaoma T, Helle D, Brochin L, Rech F, Peyre M, Labrousse F, Vallar L, Guéant JL, Vignaud JM, Battaglia-Hsu SF.

J Pathol. 2017 Aug;242(4):421-434. doi: 10.1002/path.4916. Epub 2017 Jul 5.

PMID:
28493484
20.

[Paraneoplastic hypoglycemia: The hopes of pathophysiological documentation].

Villemain A, Menard O, Mandry D, Siat J, Vignaud JM, Martinet Y, Tiotiu A.

Rev Pneumol Clin. 2017 Jun;73(3):140-145. doi: 10.1016/j.pneumo.2017.03.001. Epub 2017 Apr 12. French.

PMID:
28410845
21.

Endothelial Cell Hypertrophy and Microvascular Proliferation in Meningiomas Are Correlated with Higher Histological Grade and Shorter Progression-Free Survival.

Ling C, Pouget C, Rech F, Pflaum R, Treffel M, Bielle F, Mokhtari K, Casse JM, Vignaud JM, Kalamarides M, Peyre M, Gauchotte G.

J Neuropathol Exp Neurol. 2016 Dec 1;75(12):1160-1170. doi: 10.1093/jnen/nlw095.

PMID:
27807004
22.

Mitotic index, microvascular proliferation, and necrosis define 3 pathological subgroups of prognostic relevance among 1p/19q co-deleted anaplastic oligodendrogliomas.

Figarella-Branger D, Mokhtari K, Dehais C, Carpentier C, Colin C, Jouvet A, Uro-Coste E, Forest F, Maurage CA, Vignaud JM, Polivka M, Lechapt-Zalcman E, Eimer S, Viennet G, Quintin-Roué I, Aubriot-Lorton MH, Diebold MD, Loussouarn D, Lacroix C, Rigau V, Laquerrière A, Vandenbos F, Michalak S, Sevestre H, Peoch M, Labrousse F, Christov C, Kemeny JL, Chenard MP, Chiforeanu D, Ducray F, Idbaih A, Delattre JY; POLA Network.

Neuro Oncol. 2016 Jun;18(6):888-90. doi: 10.1093/neuonc/now085. No abstract available.

23.

Three Rounds of External Quality Assessment in France to Evaluate the Performance of 28 Platforms for Multiparametric Molecular Testing in Metastatic Colorectal and Non-Small Cell Lung Cancer.

Dequeker EM, Keppens C, Egele C, Delen S, Lamy A, Lemoine A, Sabourin JC, Andrieu C, Ligtenberg M, Fetique D, Tops B, Descarpentries C, Blons H, Denoux Y, Aube C, Penault-Llorca F, Hofman P, Leroy K, Le Marechal C, Doucet L, Duranton-Tanneur V, Pedeutour F, Soubeyran I, Côté JF, Emile JF, Vignaud JM, Monhoven N, Haddad V, Laurent-Puig P, van Krieken H, Nowak F, Lonchamp E, Bellocq JP, Rouleau E.

J Mol Diagn. 2016 Mar;18(2):205-14. doi: 10.1016/j.jmoldx.2015.09.004. Epub 2016 Jan 2.

PMID:
26752307
24.

[Squamous cell carcinoma, basaloid squamous cell carcinoma and adenosquamous carcinoma in the lung].

Vignaud JM.

Ann Pathol. 2016 Jan;36(1):15-23. doi: 10.1016/j.annpat.2015.11.011. Epub 2015 Dec 30. Review. French.

PMID:
26746368
25.

SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas.

Le Loarer F, Watson S, Pierron G, de Montpreville VT, Ballet S, Firmin N, Auguste A, Pissaloux D, Boyault S, Paindavoine S, Dechelotte PJ, Besse B, Vignaud JM, Brevet M, Fadel E, Richer W, Treilleux I, Masliah-Planchon J, Devouassoux-Shisheboran M, Zalcman G, Allory Y, Bourdeaut F, Thivolet-Bejui F, Ranchere-Vince D, Girard N, Lantuejoul S, Galateau-Sallé F, Coindre JM, Leary A, Delattre O, Blay JY, Tirode F.

Nat Genet. 2015 Oct;47(10):1200-5. doi: 10.1038/ng.3399. Epub 2015 Sep 7.

PMID:
26343384
26.

Correlation of SUV-Derived Indices With Tumoral Aggressiveness of Gliomas in Static 18F-FDOPA PET: Use in Clinical Practice.

Janvier L, Olivier P, Blonski M, Morel O, Vignaud JM, Karcher G, Taillandier L, Verger A.

Clin Nucl Med. 2015 Sep;40(9):e429-35. doi: 10.1097/RLU.0000000000000897.

PMID:
26204212
27.

Skin wounds vitality markers in forensic pathology: An updated review.

Casse JM, Martrille L, Vignaud JM, Gauchotte G.

Med Sci Law. 2016 Apr;56(2):128-37. doi: 10.1177/0025802415590175. Epub 2015 Jun 21. Review.

PMID:
26101444
28.

In malignant cartilagenous tumors, immunohistochemical expression of procollagen PC1CP peptide is higher and that of PC2CP lower than in benign cartilaginous lesions.

Delaunay-Lemarie C, Vincourt JB, Marie B, Battaglia-Hsu SF, Etienne S, Sirveaux F, Nguyen Thi PL, Magdalou J, Vignaud JM, Gauchotte G.

Virchows Arch. 2015 Sep;467(3):329-37. doi: 10.1007/s00428-015-1799-3. Epub 2015 Jun 23.

PMID:
26100916
29.

Methyl(R217)HuR and MCM6 are inversely correlated and are prognostic markers in non small cell lung carcinoma.

Vigouroux C, Casse JM, Battaglia-Hsu SF, Brochin L, Luc A, Paris C, Lacomme S, Gueant JL, Vignaud JM, Gauchotte G.

Lung Cancer. 2015 Aug;89(2):189-96. doi: 10.1016/j.lungcan.2015.05.008. Epub 2015 May 16.

PMID:
26013954
30.

French multicentric validation of ALK rearrangement diagnostic in 547 lung adenocarcinomas.

Lantuejoul S, Rouquette I, Blons H, Le Stang N, Ilie M, Begueret H, Grégoire V, Hofman P, Gros A, Garcia S, Monhoven N, Devouassoux-Shisheboran M, Mansuet-Lupo A, Thivolet F, Antoine M, Vignaud JM, Penault-Llorca F, Galateau-Sallé F, McLeer-Florin A.

Eur Respir J. 2015 Jul;46(1):207-18. doi: 10.1183/09031936.00119914. Epub 2015 Apr 30.

31.

Zosteriform configuration of multiple eccrine spiradenomas of the scalp.

Sorin T, Vignaud JM, Colson T, Gauchotte G, De Runz A, Brix M, Cuny JF, Simon E.

Ann Chir Plast Esthet. 2016 Feb;61(1):65-8. doi: 10.1016/j.anplas.2014.12.001. Epub 2014 Dec 30.

PMID:
25555434
32.

Prognostic Relevance of Histomolecular Classification of Diffuse Adult High-Grade Gliomas with Necrosis.

Figarella-Branger D, Mokhtari K, Colin C, Uro-Coste E, Jouvet A, Dehais C, Carpentier C, Villa C, Maurage CA, Eimer S, Polivka M, Vignaud JM, Laquerriere A, Sevestre H, Lechapt-Zalcman E, Quintin-Roué I, Aubriot-Lorton MH, Diebold MD, Viennet G, Adam C, Loussouarn D, Michalak S, Rigau V, Heitzmann A, Vandenbos F, Forest F, Chiforeanu D, Tortel MC, Labrousse F, Chenard MP, Nguyen AT, Varlet P, Kemeny JL, Levillain PM, Cazals-Hatem D, Richard P, Delattre JY; POLA Network.

Brain Pathol. 2015 Jul;25(4):418-28. doi: 10.1111/bpa.12227. Epub 2014 Dec 31.

PMID:
25407774
33.

"Sentinel" circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease.

Ilie M, Hofman V, Long-Mira E, Selva E, Vignaud JM, Padovani B, Mouroux J, Marquette CH, Hofman P.

PLoS One. 2014 Oct 31;9(10):e111597. doi: 10.1371/journal.pone.0111597. eCollection 2014.

34.

Olfactory neuroblastoma behavior inside and outside the olfactory cleft.

Jankowski R, Russel A, Gallet P, Henrot P, Vignaud JM, Nguyen DT.

Surg Radiol Anat. 2015 Jul;37(5):507-15. doi: 10.1007/s00276-014-1375-6. Epub 2014 Sep 14.

PMID:
25218517
35.

Respiratory epithelial adenomatoid hamartoma of the nose: an updated review.

Nguyen DT, Gauchotte G, Arous F, Vignaud JM, Jankowski R.

Am J Rhinol Allergy. 2014 Sep-Oct;28(5):187-92. doi: 10.2500/ajra.2014.28.4085. Review.

PMID:
25198016
36.

Value of integron detection for predicting antibiotic resistance in patients with Gram-negative septicaemia.

Barraud O, François B, Chainier D, Vignaud J, Ploy MC.

Int J Antimicrob Agents. 2014 Oct;44(4):351-3. doi: 10.1016/j.ijantimicag.2014.06.008. Epub 2014 Jul 23.

PMID:
25130099
37.

Predictors of respiratory epithelial adenomatoid hamartomas of the olfactory clefts in patients with nasal polyposis.

Nguyen DT, Nguyen-Thi PL, Gauchotte G, Arous F, Vignaud JM, Jankowski R.

Laryngoscope. 2014 Nov;124(11):2461-5. doi: 10.1002/lary.24778. Epub 2014 Jun 13.

PMID:
24925105
38.

BRAFV600E mutation analysis by immunohistochemistry in patients with thoracic metastases from colorectal cancer.

Ilie MI, Long-Mira E, Hofman V, Mouroux J, Vignaud JM, Gauchotte G, Begueret H, Merlio JP, Emile JF, Hébuterne X, Hofman P.

Pathology. 2014 Jun;46(4):311-5. doi: 10.1097/PAT.0000000000000113.

PMID:
24798160
39.

Mitotic index, microvascular proliferation, and necrosis define 3 groups of 1p/19q codeleted anaplastic oligodendrogliomas associated with different genomic alterations.

Figarella-Branger D, Mokhtari K, Dehais C, Jouvet A, Uro-Coste E, Colin C, Carpentier C, Forest F, Maurage CA, Vignaud JM, Polivka M, Lechapt-Zalcman E, Eimer S, Viennet G, Quintin-Roué I, Aubriot-Lorton MH, Diebold MD, Loussouarn D, Lacroix C, Rigau V, Laquerrière A, Vandenbos F, Michalak S, Sevestre H, Peoch M, Labrousse F, Christov C, Kemeny JL, Chenard MP, Chiforeanu D, Ducray F, Idbaih A; POLA Network.

Neuro Oncol. 2014 Sep;16(9):1244-54. doi: 10.1093/neuonc/nou047. Epub 2014 Apr 9.

40.

[Bronchioloalveolar carcinoma: an exceptional cause of diffuse lung disease in a patient with acute myeloid leukemia].

Boubaya A, Gomez E, Guerder A, Ropion-Michaux H, Kheir A, Vignaud JM, Chaouat A, Chabot F.

Rev Mal Respir. 2014 Mar;31(3):259-62. doi: 10.1016/j.rmr.2013.07.003. Epub 2013 Aug 23. French.

PMID:
24680118
41.

[The French mesothelioma network from 1998 to 2013].

Galateau-Sallé F, Gilg Soit Ilg A, Le Stang N, Brochard P, Pairon JC, Astoul P, Frenay C, Blaizot G, Chamming's S, Ducamp S, Rousvoal T, de Quillacq A, Abonnet V, Abdalsamad I, Begueret H, Brambilla E, Capron F, Copin MC, Danel C, de Lajartre AY, Foulet-Roge A, Garbe L, Groussard O, Giusiano S, Hofman V, Lantuejoul S, Piquenot JM, Rouquette I, Sagan C, Thivolet-Bejui F, Vignaud JM, Scherpereel A, Jaurand MC, Jean D, Hainaut P, Chérié-Challine L, Goldberg M, Luce D, Imbernon E.

Ann Pathol. 2014 Feb;34(1):51-63. doi: 10.1016/j.annpat.2014.01.009. Epub 2014 Feb 26. French.

42.

Is there a relationship between the presence of lung mucosa preinvasive lesions and lung cancer incidence? Influence of tobacco consumption.

Clément-Duchêne C, Alla F, Gauchotte G, Marie B, Carnin C, Menard O, Vignaud JM, Martinet Y.

Lung Cancer. 2014 May;84(2):134-8. doi: 10.1016/j.lungcan.2014.02.003. Epub 2014 Feb 16.

PMID:
24589076
43.

[A sudden cardiac arrest during the anesthesia induction].

Chapelet A, Audibert G, Plénat F, Vignaud JM, Gauchotte G.

Ann Pathol. 2013 Dec;33(6):426-8. doi: 10.1016/j.annpat.2013.10.006. Epub 2013 Nov 20. Review. French. No abstract available.

PMID:
24331728
44.

[2014 classification of lung carcinomas: latest entities and clinical implications. Case 2: Basaloid carcinoma].

Vignaud JM.

Ann Pathol. 2013 Oct;33(5):311-3. doi: 10.1016/j.annpat.2013.09.013. Epub 2013 Oct 23. French. No abstract available.

PMID:
24238240
45.

[2014 classification of lung carcinomas: latest entities and clinical implications. Case 1: Poorly differentiated non small cell lung carcinoma: interpretation of small biopsy specimens].

Vignaud JM.

Ann Pathol. 2013 Oct;33(5):306-10. doi: 10.1016/j.annpat.2013.09.015. Epub 2013 Oct 23. French. No abstract available.

PMID:
24238239
46.

[2014 classification of lung carcinomas: latest entities and clinical implications. Introduction].

Lantuejoul S, Vignaud JM, Copin MC, Badoual C.

Ann Pathol. 2013 Oct;33(5):304-5. doi: 10.1016/j.annpat.2013.09.011. Epub 2013 Oct 23. French. No abstract available.

PMID:
24238238
47.

CARM1 and PRMT1 are dysregulated in lung cancer without hierarchical features.

Elakoum R, Gauchotte G, Oussalah A, Wissler MP, Clément-Duchêne C, Vignaud JM, Guéant JL, Namour F.

Biochimie. 2014 Feb;97:210-8. doi: 10.1016/j.biochi.2013.10.021. Epub 2013 Nov 6.

PMID:
24211191
48.

Is pneumosinus dilatans an osteogenic disease that mimics the formation of a paranasal sinus?

Jankowski R, Kuntzler S, Boulanger N, Morel O, Tisserant J, Benterkia N, Vignaud JM.

Surg Radiol Anat. 2014 Jul;36(5):429-37. doi: 10.1007/s00276-013-1222-1. Epub 2013 Oct 27.

PMID:
24162268
49.

Respiratory epithelial adenomatoid hamartoma: a poorly recognized entity with mast cell recruitment and frequently associated with nasal polyposis.

Gauchotte G, Marie B, Gallet P, Nguyen DT, Grandhaye M, Jankowski R, Vignaud JM.

Am J Surg Pathol. 2013 Nov;37(11):1678-85. doi: 10.1097/PAS.0000000000000092.

PMID:
24121171
50.

Microscopic features for initial diagnosis and disease activity evaluation in inflammatory bowel disease.

Bressenot A, Geboes K, Vignaud JM, Guéant JL, Peyrin-Biroulet L.

Inflamm Bowel Dis. 2013 Jul;19(8):1745-52. doi: 10.1097/MIB.0b013e318281f2e8. Review.

PMID:
23782793

Supplemental Content

Loading ...
Support Center